Measurement of gas-concentration-driven permeation for the examination of permeability, solubility, and diffusivity in varying materials

This manuscript describes the development and operation of an apparatus for the measurement of steady-state and transient gas permeation through different types of solid materials with varying geometries. It is capable of operation from 293 K to 673 K and could theoretically be used with any non-corrosive gas or a mix of gases, although only hydrogen isotopes are used in the current study. A quadrupole mass spectrometer is used to measure permeation fluxes as low as 10¹¹ molecules/s. This unique test setup allows for the simultaneous measurement of diffusivity, solubility, and permeability. Furthermore, varying the pressure in the fore-sample volume allows for tests of Sievert's law and can give information on surface effects.

Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence

One of the greatest challenges in cancer therapy is to develop methods to deliver chemotherapy agents to tumor cells while reducing systemic toxicity to noncancerous cells. A promising approach to localizing drug release is to employ drug-loaded nanoparticles with coatings that release the drugs only in the presence of specific triggers found in the target cells such as pH, enzymes, or light. However, many parameters affect the nanoparticle distribution and drug release rate, and it is difficult to quantify drug release in situ. In this work, we show proof-of-principle for a "smart" radioluminescent nanocapsule with an X-ray excited optical luminescence (XEOL) spectrum that changes during release of the optically absorbing chemotherapy drug, doxorubicin. XEOL provides an almost background-free luminescent signal for measuring drug release from particles irradiated by a narrow X-ray beam. We study in vitro pH-triggered release rates of doxorubicin from nanocapsules coated with a pH-responsive polyelectrolyte multilayer using HPLC and XEOL spectroscopy. The doxorubicin was loaded to over 5% by weight and released from the capsule with a time constant in vitro of ∼36 days at pH 7.4 and 21 h at pH 5.0, respectively. The Gd₂O₂S:Eu nanocapsules are also paramagnetic at room temperature with similar magnetic susceptibility and similarly good MRI T₂ relaxivities to Gd₂O₃, but the sulfur increases the radioluminescence intensity and shifts the spectrum. Empty nanocapsules did not affect cell viability up to concentrations of at least 250 μg/mL. These empty nanocapsules accumulated in a mouse liver and spleen following tail vein injection and could be observed in vivo using XEOL. The particles are synthesized with a versatile template synthesis technique which allows for control of particle size and shape. The XEOL analysis technique opens the door to noninvasive quantification of drug release as a function of nanoparticle size, shape, surface chemistry, and tissue type.

Sonographic determination of fetal gender

With the advent of high resolution real-time sonographic scanning machines, fetal gender can be determined in most pregnancies of more than 25 weeks. In 72 of 112 consecutive pregnancies, fetal genitalia were well visualized and there were no errors in prediction of fetal gender. In the 40 failures, the fetal genitalia could not be detected, hence, determination was not volunteered. Follow-up showed that the failure group was equally divided between males and females, emphasizing that lack of visualization did not imply a female perineum. The reasons for failure and success, scanning techniques, and a brief review of fetal genital embryology are discussed. Caution of potential psychological effects on the parents is raised.